Vis enkel innførsel

dc.contributor.authorHansen, Anneli Borge
dc.contributor.authorBaste, Valborg
dc.contributor.authorHetlevik, Øystein
dc.contributor.authorHaukenes, Inger
dc.contributor.authorSmith-Sivertsen, Tone
dc.contributor.authorRuths, Sabine
dc.date.accessioned2021-02-12T11:52:30Z
dc.date.available2021-02-12T11:52:30Z
dc.date.created2021-01-05T08:37:07Z
dc.date.issued2021
dc.identifier.issn2398-3795
dc.identifier.urihttps://hdl.handle.net/11250/2727733
dc.description.abstractBackground: Antidepressant drugs are often prescribed in general practice. Evidence is conflicting on how patient education influences antidepressant treatment. Aim: To investigate the association between educational attainment and drug treatment in adult patients with a new depression diagnosis, and to what extent gender and age influence the association. Design and setting: Nationwide registry-based cohort study, Norway, 2014-2016. Method: The study comprised all residents of Norway born before 1996 and alive in 2015. We obtained information on all new depression diagnoses in general practice in 2015 (Primary Care Database) and data on all dispensed depression medication (Norwegian Prescription Database) 12-months after the date of diagnosis. Independent variables were education, gender, and age. Associations with drug treatment were estimated using a Cox proportional hazard model, for genders separately. Results: Out of 49,967 patients with new depression (61.6% women), 15,678 were dispensed drugs (30.4% women, 33.0% men). Highly educated women were less likely to receive medication (Hazard Ratio (HR) =0.93, 95% CI (0.88 – 0.98)) than women with low education. No such differences appeared among men. Women aged 20-29 were more likely to be treated with drugs than those aged 30-59, and women aged 70+ were more likely to receive drugs (HR=1.65, (1.54 – 1.77)) than those aged 20-29. The pattern was similar but less pronounced for men. Conclusion: Educational differences in antidepressant therapy among women may reflect different treatment approaches that clinicians should be aware of to avoid unintended variation. Reasons for this variation and consequences for quality of treatment should be explored.
dc.language.isoengen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.subjectDepresjon
dc.subjectDepression
dc.subjectAntidepressive midler
dc.subjectAntidepressants
dc.subjectHelsetjenesteforskning
dc.subjectHealth services research
dc.subjectFastlege
dc.subjectGeneral practitioner
dc.titleGeneral practitioners’ drug treatment for depression by patients’ educational level: registry-based studyen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.rights.holder© 2020, Authors
dc.description.versionpublishedVersion
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doihttps://doi.org/10.3399/BJGPO-2020-0122
dc.identifier.cristin1865268
dc.source.journalBritish Journal of General Practice Openen_US
dc.relation.projectNorges forskningsråd: 287884
dc.subject.nsiVDP::Allmennmedisin: 751
dc.subject.nsiVDP::General practice: 751


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal